Sanchez et al. [22] reported that CGA acted as either an insulin secretagogue or a PPARα/γ dual agonist, and Ghadieh et al. [25] demonstrated that CGA/chromium supplementation alleviates insulin resistance. The gene discussed is PPARA; the disease is Insulin resistance.